Bartlett & Co. LLC Abb Vie Inc. Transaction History

Bartlett & Co. LLC

$6.16 Billion
Q4 2023

A detailed history of Bartlett & Co. LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bartlett & Co. LLC holds 124,971 shares of ABBV stock, worth $21.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

124,971

Previous 122,922 1.67%

Holding current value

$21.9 Million

Previous $18.3 Million 5.54%

% of portfolio

0.31%

Previous 0.33%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$137.6 - $154.97 $281,942 - $317,533	2,049 Added 1.67%	124,971 $19.3 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $228,438 - $264,451	-1,710 Reduced 1.37%	122,922 $18.3 Million
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $1.58 Million - $1.97 Million	11,950 Added 10.61%	124,632 $16.8 Million
Q1 2023 Apr 06, 2023	SELL	$144.61 - $166.54 $210,841 - $242,815	-1,458 Reduced 1.28%	112,682 $18 Million
Q4 2022 Jan 04, 2023	SELL	$138.31 - $165.87 $9,958 - $11,942	-72 Reduced 0.06%	114,140 $18.4 Million
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $248,556 - $285,078	1,852 Added 1.65%	114,212 $15.3 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $114,224 - $145,216	-830 Reduced 0.73%	112,360 $17.2 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $154,812 - $192,078	1,173 Added 1.05%	113,190 $18.3 Million
Q4 2021 Mar 08, 2022	SELL	$107.43 - $135.93 $406,622 - $514,495	-3,785 Reduced 3.27%	112,017 $15.2 Million
Q3 2021 Oct 15, 2021	SELL	$106.4 - $120.78 $28,728 - $32,610	-270 Reduced 0.23%	115,802 $12.5 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $197,163 - $219,651	-1,874 Reduced 1.59%	116,072 $13.1 Million
Q1 2021 Apr 19, 2021	SELL	$102.3 - $112.62 $324,802 - $357,568	-3,175 Reduced 2.62%	117,946 $12.8 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $89,424 - $120,732	-1,111 Reduced 0.91%	121,121 $13 Million
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $124,999 - $146,707	-1,455 Reduced 1.18%	122,232 $10.7 Million
Q2 2020 Aug 03, 2020	SELL	$73.37 - $98.18 $111,889 - $149,724	-1,525 Reduced 1.22%	123,687 $12.1 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $237,876 - $360,649	-3,688 Reduced 2.86%	125,212 $9.54 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $1.18 Million - $1.42 Million	18,767 Added 17.04%	128,900 $9.76 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $151,110 - $193,154	-2,300 Reduced 2.05%	110,133 $8.01 Million
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $340,187 - $400,383	-4,410 Reduced 3.77%	112,433 $0
Q4 2018 Jan 23, 2019	SELL	$77.85 - $96.01 $312,178 - $385,000	-4,010 Reduced 3.32%	116,843 $10.8 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $138,788 - $154,289	-1,561 Reduced 1.28%	120,853 $11.4 Million
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $15,711 - $18,590	175 Added 0.14%	122,414 $11.3 Million
Q1 2018 Apr 25, 2018	SELL	$92.01 - $123.21 $1.02 Million - $1.37 Million	-11,138 Reduced 8.35%	122,239 $11.6 Million
Q4 2017 Jan 19, 2018	SELL	$89.56 - $98.21 $184,941 - $202,803	-2,065 Reduced 1.52%	133,377 $12.9 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $9.46 Million - $12.1 Million	135,442	135,442 $12 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.

Account